Lunai Bioworks Inc. Stock Issued During Period, Shares, Period Increase (Decrease)
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- Lunai Bioworks Inc. stock issued during period, shares, period increase (decrease) for the quarter ending 2024-03-31 was 0.00 shares.
- Lunai Bioworks Inc. stock issued during period, shares, period increase (decrease) for the quarter ending 2023-12-31 was 0.00 shares.
- Lunai Bioworks Inc. stock issued during period, shares, period increase (decrease) for the quarter ending 2023-09-30 was 0.00 shares.
| Period end | Stock Issued During Period, Shares, Period Increase (Decrease) 3 month | Stock Issued During Period, Shares, Period Increase (Decrease) 12 month |
|---|---|---|
| 2024-03-31 | 0.00 shares 10-Q/A · filed 2025-02-19 | |
| 2023-12-31 | 0.00 shares 10-Q · filed 2024-02-14 | |
| 2023-09-30 | 0.00 shares 10-Q · filed 2023-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PMV Pharmaceuticals, Inc. (PMVP) | United States | $0.071B | -0.95 |
| TENAX THERAPEUTICS, INC. (TENX) | United States | $0.071B | -7.17 |
| PLIANT THERAPEUTICS, INC. (PLRX) | United States | $0.071B | -0.76 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Yarrow Bioscience, Inc. (YARW) | United States | $0.070B | |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| Connect Biopharma Holdings Ltd (CNTB) | $0.069B | -2.17 | |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |
| Verrica Pharmaceuticals Inc. (VRCA) | United States | $0.076B | -3.39 |